Using Hemoglobin Spectra as an Indicator for Some Blood Diseases

2013 ◽  
Vol 25 (1) ◽  
Author(s):  
Nabeel Al Ama ◽  
Taha Kumosani
Keyword(s):  
Blood Diseases ◽  
Hemoglobin Spectra

Peculiarities of the course of type I allergic reactions in patients with blood diseases

2020 ◽  
pp. 40-50
Author(s):  
A. Nikitina
Keyword(s):  
Search Engines ◽  
Anaphylactic Shock ◽  
Type I ◽  
Allergic Reactions ◽  
Common Cause ◽  
Blood Diseases ◽  
Treatment Regimens ◽  
Modern Methods

Analysis of literature data presented in search engines — Elibrary, PubMed, Cochrane — concerning the risk of developing type I allergic reactions in patients with blood diseases is presented. It is shown that the most common cause of type I allergic reactions is drugs included in the treatment regimens of this category of patients. The article presents statistics on the increase in the number of drug allergies leading to cases of anaphylactic shock in patients with blood diseases. Modern methods for the diagnosis of type I allergic reactions in vivo and in vitro are considered.

THREE EXPERIMENTAL BLOOD DISEASES

1932 ◽  
Vol 25 (3) ◽  
pp. 318-319
Author(s):  
M Y DABNEY ◽  
EUGENIA B. DABNEY ◽  
C P LORANZ
Keyword(s):  
Blood Diseases

DISORDERS OF BLOOD AND BLOOD-FORMING ORGANS IN CHILDHOOD, H. S. Baar, Stella Baar, K. B. Rogers, and E. Stransky, New York, Hafner Publishing Company, 1963, 902 pp., $60.00

PEDIATRICS ◽  
1963 ◽  
Vol 32 (4) ◽  
pp. 647-647
Author(s):  
Irving Schulman
Keyword(s):  
New York ◽  
Publishing Company ◽  
Blood Diseases ◽  
Pediatric Hematology ◽  
Present Volume ◽  
The Face

Drs. H. S. Baar and E. Stransky published in 1928 one of the first books devoted exclusively to blood diseases in children. The present volume represents an attempt by these writers and their co-authors to produce, in the face of serious obstacles, a modern text on the same subject. The senior authors have been separated from each other by vast distances and the careers of both were turned away from specialization in pediatric hematology over twenty years ago.

Recurrent deep vein thromboses in children with blood diseases. The results of a single center trial

2019 ◽  
Author(s):  
П.А. Жарков ◽  
Д.С. Морозова ◽  
Д.А. Евстратов ◽  
Д.В. Федорова ◽  
Ю.А. Шифрин ◽  
...  
Keyword(s):  
Lymphoblastic Leukemia ◽  
Secondary Prophylaxis ◽  
Future Research ◽  
Hospitalized Children ◽  
Recurrent Thrombosis ◽  
Bone Marrow Aplasia ◽  
Single Episode ◽  
Blood Diseases ◽  
Vein Thrombosis ◽  
Deep Vein

Введение. Тромбозы глубоких вен (ТГВ) являются нередким осложнением течения и лечения у детей с заболеваниями крови и требуют проведения антитромботической терапии и профилактики для снижения количества повторных тромботических эпизодов. Цель исследования: анализ частоты и определение факторов риска повторных ТГВ у детей, госпитализированных для лечения заболеваний крови. Материалы и методы. Проведен ретроспективный анализ электронной базы данных пациентов в возрасте от 0 до 17 лет включительно, которым проводили стационарное лечение гемобластозов и синдромов костномозговой недостаточности в период 01.0.2012 по 31.12.2017. В анализ вошли только те пациенты, у которых было зарегистрировано более 1 случая тромбоза. Результаты. Рецидивы тромбозов наблюдали у 13,3 детей с асимптоматическими (аТГВ) и у 5,4 с симптоматическими (сТГВ) ТГВ. Рецидивы аТГВ при остром лимфобластном лейкозе (ОЛЛ) выявлены у 14,5, при остром миелобластном лейкозе (ОМЛ) у 8,9, при лимфоме у 11,9. У детей с сТГВ рецидивы тромбоза выявлены при ОЛЛ у 8,2, при ОМЛ у 8,3, при лимфоме у 2,8 пациентов. Медиана возраста пациентов с единственным эпизодом сТГВ составила 10 лет, с рецидивом сТГВ 9 лет, при аТГВ 7 лет для пациентов с единственным эпизодом и 6 лет с рецидивом аТГВ. Некорректно проведенная терапия была зарегистрирована у 50 детей. Заключение. Рецидивирующее течение тромбоза у детей, госпитализированных для лечения заболеваний крови, уста новлено у 5,4 детей с сТГВ и у 13,3 детей с аТГВ, причем 1/3 часть сТГВ является потенциально жизнеугрожающей. Полученные данные подчеркивают необходимость проведения вторичной антитромботической профилактики у детей с ТГВ и ставят вопрос о необходимости и целесообразности проведения таковой у пациентов с аТГВ. Introduction. Deep vein thrombosis (DVT) remains a common complication of hematological diseases in children and requires antithrombotic therapy and prophylaxis of recurrent thrombotic events. Aim: to determine incidence and risk factors of recurrent DVT for hospitalized children with blood diseases. Materials and methods. Medical records of patients hospitalized with oncohematological diseases and bone marrow aplasia, aged from 0 to 17 years, were analyzed retrospectively. Only patients with more than one DVT were taken into this analysis. Results. Recurrent DVT was diagnosed in 13.27 children with asymptomatic DVT (aDVT) and in 5.41 with symptomatic DVT (sDVT). Recurrent DVT was found in 14.49 children with acute lymphoblastic leukemia (ALL), in 8.89 with acute myeloblastic leukaemia (AML), in 11.86 with lymphomas. Incidence of recurrent thrombosis in children with sDVT was 8.16 for ALL, 8.33 for AML, 2.78 for lymphomas. Age analysis of patients with the single episode and recurrent thrombosis showed that age median with single sDVT was 10 years, recurrent DVT 9 years, in case of single asymptomatic or incidental (aDVT) episode 7 years, recurrent DVT 6 years. Incorrect therapy was registered for 50 of children with recurrent sDVT. Conclusion. Recurrent DVT in hospitalized children with blood diseases occurred in 5.41 children with sDVT and in children 13.33 with aDVT 1/3 episodes of sDVT was lifethreatening. In conclusion, secondary prophylaxis is needed for children with DVT and future research should be done for prophylaxis in those with aDVT.

Sign in / Sign up

Export Citation Format

Share Document